NCT02964429 is a NA clinical trial of Diacap Pro High-Flux in Kidney Failure,Chronic, sponsored by B.Braun Avitum AG.

Who is sponsoring NCT02964429?

NCT02964429 is sponsored by B.Braun Avitum AG.

What drugs are being tested in NCT02964429?

Interventions in NCT02964429: Diacap Pro High-Flux.

What condition does NCT02964429 study?

NCT02964429 studies Kidney Failure,Chronic, Renal Insufficiency,Chronic, Kidney Disease, End-Stage, Kidney Insufficiency.

Is NCT02964429 still recruiting?

NCT02964429 is currently completed. Last updated 7 February 2017.

Last reviewed 2017-02-07 · How we verify

NCT02964429

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Determination In-vivo KUF for Diacap Pro Hemodialyser

Completed NA Last updated 7 February 2017

What this trial tests

NA trial testing Diacap Pro High-Flux in Kidney Failure,Chronic in 12 participants. Completed in 23 December 2016.

Timeline

14 November 2016

Primary endpoint
23 December 2016

23 December 2016

Quick facts

Lead sponsor	B.Braun Avitum AG
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	12
Start date	14 November 2016
Primary completion	23 December 2016
Estimated completion	23 December 2016
Sites	1 location across Czechia

Drugs / interventions tested

Diacap Pro High-Flux

Conditions studied

Kidney Failure,Chronic — all drugs for Kidney Failure,Chronic →
Renal Insufficiency,Chronic — all drugs for Renal Insufficiency,Chronic →
Kidney Disease, End-Stage — all drugs for Kidney Disease, End-Stage →
Kidney Insufficiency — all drugs for Kidney Insufficiency →

Sponsor

B.Braun Avitum AG

Who can join

18 and older, any sex, with Kidney Failure,Chronic or Renal Insufficiency,Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of this study is the determination of the in-vivo ultrafiltration coefficient (in-vivo KUF) for Diacap Pro dialyzers following routine dialysis prescription in the United States.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Kidney Failure,Chronic

Currently open trials in the same condition.

NCT06917950 — Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02964429 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by B.Braun Avitum AG
Last refreshed: 7 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02964429.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing